The European Commission will send a letter to AstraZeneca as part of its strategy to resolve the dispute with the Anglo-Swedish company over its supplies of COVID-19 vaccines to the bloc, a spokesman for the EU executive said on Thursday.
“We plan to send a letter to AstraZeneca that will allow us to begin a dialogue with the company as part of a process to resolve the dispute,” the spokesman told a news conference.
He added the letter was under preparation and would be discussed with EU governments before sending it.